Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86606 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86884 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Resolved | 2019-11-28 | 2025-04-28 | 99938 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Resolved | 2020-07-30 | 2025-04-28 | 121497 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2021-02-18 | 2025-04-28 | 134352 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116669 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2020-07-30 | 2020-09-17 | 121512 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2020-10-01 | 2020-11-26 | 125506 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2020-10-15 | 2020-11-26 | 126522 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2021-11-04 | 2021-11-11 | 148841 |
| TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2023-07-11 | 2023-10-04 | 198312 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2024-06-07 | 2024-09-19 | 229951 |
| TEVA-MELOXICAM | 15MG | TABLET | Resolved | 2025-07-18 | 2025-11-20 | 263134 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2023-10-05 | 2024-08-27 | 206389 |
| TEVA-METFORMIN | 500MG | TABLET | Resolved | 2023-10-19 | 2023-12-07 | 207521 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2023-11-09 | 2024-05-09 | 209675 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2024-02-22 | 2024-05-09 | 220264 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2024-03-07 | 2024-08-27 | 221549 |
| TEVA-METFORMIN | 500MG | TABLET | Resolved | 2024-03-28 | 2024-08-27 | 223841 |
| TEVA-METFORMIN | 500MG | TABLET | Resolved | 2024-04-11 | 2024-08-27 | 224892 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LAMOTRIGINE | 25MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81388 |
| TEVA-LAMOTRIGINE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258646 |
| TEVA-LAMOTRIGINE | 150MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258652 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-25 | 2025-04-25 | 255824 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256085 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258507 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258510 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Discontinued | 2020-07-10 | 2020-07-10 | 120009 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258625 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |
| TEVA-LISINOPRIL (TYPE P) | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81400 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104257 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Discontinued | 2019-08-15 | 2019-08-15 | 91648 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258694 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258699 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81301 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |